Binh Dinh Pharmaceutical and Medical Equipment Stock

Equities

DBD

VN000000DBD0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 06:00:00 2024-06-25 pm EDT 5-day change 1st Jan Change
40,550 VND -1.10% Intraday chart for Binh Dinh Pharmaceutical and Medical Equipment -4.14% -6.48%
Sales 2024 * 1,844B 71.92M Sales 2025 * - Capitalization 3,794B 148M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 2.06 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 1,318
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.54%
More Fundamentals * Assessed data
Dynamic Chart
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves Earnings Guidance for the Year 2024 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Executive Changes CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Board and Committee Changes CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Appointment of Pham Thi Thanh Huong as CEO CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Appointment of Huynh Ngoc Oanh as Deputy CEO CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Approves Dividend for the Year 2022 and Provides Dividend Guidance for the Year 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves Earnings Guidance for the Year 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Approves to Implement the Investment Plan to Build the Production Factory CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces the Change in Personnel, Effective from April 21, 2023 CI
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company Announces Board Changes CI
More news
1 day-1.10%
1 week-4.14%
Current month-3.27%
1 month-3.45%
3 months-9.81%
6 months-4.72%
Current year-6.48%
More quotes
1 week
40 200.00
Extreme 40200
42 500.00
1 month
40 200.00
Extreme 40200
43 500.00
Current year
40 000.00
Extreme 40000
45 920.00
1 year
39 520.00
Extreme 39520
48 000.00
3 years
24 615.38
Extreme 24615.3846
48 000.00
5 years
23 440.56
Extreme 23440.5594
48 000.00
10 years
19 580.42
Extreme 19580.4196
48 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 09-12-31
Chairman 63 83-04-30
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 45 21-04-16
Chairman 63 83-04-30
Chief Executive Officer 58 09-12-31
More insiders
Date Price Change Volume
24-06-26 40,550 -1.10% 19,200
24-06-25 41,000 -0.97% 42,700
24-06-24 41,400 -1.43% 104,600
24-06-21 42,000 -0.47% 87,700
24-06-20 42,200 -0.24% 144,000

End-of-day quote Ho Chi Minh S.E., June 25, 2024

More quotes
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
40,550 VND
Average target price
48,000 VND
Spread / Average Target
+18.37%
Consensus

Chiffre d''affaires - Rate of surprise